SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · RA Capital Management, L.P., a director and 10% owner, purchased $2.05M…

Artiva Biotherapeutics, Inc. · INSIDER-BUY filed Jul 31, 2026 at 17:13 ET

At the news

BULLISHIMPACT 7/10

INSIDER-BUY filed Jul 31, 2026 at 17:13 ET

RA Capital Management, L.P., a director and 10% owner, purchased $2.05M of ARTV shares in four open-market transactions over eight days (July 22-29, 2026). This represents ~0.79% of the $258M market cap and is a strong insider conviction signal, especially given the firm's sustained buying pattern ($5.0M total insider purchases in the last 30 days).

  • RA Capital Management (Director, 10% Owner) bought $2.05M of ARTV shares across 4 trades at ~$9.93-$9.99 per share.
  • Total insider purchases in the last 30 days reached $5.0M across 10 transactions.
  • Purchase represents ~0.79% of ARTV's $258M market cap, a significant proportional stake.
  • Analyst consensus is 92% bullish (4 Strong Buy, 7 Buy, 1 Hold).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access